Ligand Pharmaceuticals reported $28.43M in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acceleron Pharma XLRN:US $ -69.47M 6.84M
Amgen AMGN:US $ 3228M 40M
Anika Therapeutics ANIK:US $ 6.33M 8.56M
Arena Pharmaceuticals ARNA:US $ -123.51M 19.9M
Arrowhead Research ARWR:US $ -62379000 32.51M
Baxter International BAX:US $ 822M 124M
Bristol Myers Squibb BMY:US $ 5712M 33M
Clovis Oncology CLVS:US $ -52.17M 0.97M
Dicerna Pharmaceuticals DRNA:US $ -18.82M 19.76M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Endo International Ordinary Shares ENDP:US $ 320.03M 5.28M
Flexion Therapeutics FLXN:US $ -23631000 7.27M
Gilead Sciences GILD:US $ 4370M 1605M
GlaxoSmithKline GSK:LN 3660M 1034M
Glaxosmithkline GSK:US $ 3660M 1034M
Harsco HSC:US $ 70.54M 4.49M
Insmed INSM:US $ -91545000 6.9M
Karyopharm Therapeutics KPTI:US $ -43626000 5.19M
Lannett LCI:US $ -4.15M 8.72M
Ligand Pharmaceuticals LGND:US $ 28.43M 29.92M
Macrogenics MGNX:US $ -50191000 12.69M
Pacira Pharmaceuticals PCRX:US $ 36.49M 3.4M
Pfizer PFE:US $ 10235M 2245M
Rigel Pharmaceuticals RIGL:US $ -19.52M 6.73M
Sangamo Biosciences SGMO:US $ -45.88M 0.57M
Spectrum Pharmaceuticals SPPI:US $ -33.02M 10.98M
Teva Pharmaceutical Industries TEVA:US $ 1137M 1M
Veracyte VCYT:US $ -36.04M 41.77M